Recall events
/
Event 74588
Event summary
Timeline bucket July 01, 2016
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Dream Body Weight Loss
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
3 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 3
Dream Body Extreme Gold 800 mg 30 capsules in a plastic screw on top bottle
D-0106-2017
Recall number D-0106-2017
Initiated July 01, 2016
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Code information All lots.
Distribution pattern United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[8734]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 3
Dream Body 450 mg 30 capsules in a plastic screw on top bottle
D-0107-2017
Recall number D-0107-2017
Initiated July 01, 2016
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Code information All lots.
Distribution pattern United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9433]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 3
Dream Body Advanced 400 mg 30 capsules in brown foil packets.
D-0108-2017
Recall number D-0108-2017
Initiated July 01, 2016
Classification Class II
Status Terminated
Quantity Unknown
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Undeclared sibutramine.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Undeclared sibutramine.
Code information All lots.
Distribution pattern United States
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[9389]
FDA event record
· Exact recall-number query on openFDA
